Pharma Companies Bet on New Cholesterol Target for Heart Drugs

Novartis, Amgen, and Eli Lilly are investing in research to target a specific, lesser-known type of cholesterol, hoping it will lead to the next generation of blockbuster heart medications.

27 Apr, 17:06 — 27 Apr, 17:06

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual124d ago

Pharma bets a little-known type of cholesterol will underpin its next blockbuster heart drugs

Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.

Read full article →

Pharma Companies Bet on New Cholesterol Target for Heart Drugs

Sources

Pharma bets a little-known type of cholesterol will underpin its next blockbuster heart drugs

Related Stories

Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve

NATO Warns of Escalating Russian Gray Zone Attacks Across Europe

Investors Eye Jobs Data and Major Earnings Reports for Market Direction

North Korea Replaces Defense Minister in Military Shake-Up